Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Registration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

By Notice dated June 17, 2010, and published in the Federal Register on June 28, 2010, 75 FR 36679, Lin Zhi International Inc., 670 Almanor Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:

DrugSchedule
Tetrahydrocannabinols (7370)I
3,4-Methylenedioxymethamphetamine (MDMA) (7405)I
Cocaine (9041)II
Oxycodone (9143)II
Hydrocodone (9193)II
Methadone (9250)II
Dextropropoxyphene, bulk (non-dosage forms) (9273)II
Morphine (9300)II

The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing.Start Printed Page 22147

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Lin Zhi International Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Lin Zhi International Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with State and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Start Signature

Dated: April 13, 2011.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 2011-9611 Filed 4-19-11; 8:45 am]

BILLING CODE 4410-09-P